JP2003052806A - Blood bag - Google Patents
Blood bagInfo
- Publication number
- JP2003052806A JP2003052806A JP2001245334A JP2001245334A JP2003052806A JP 2003052806 A JP2003052806 A JP 2003052806A JP 2001245334 A JP2001245334 A JP 2001245334A JP 2001245334 A JP2001245334 A JP 2001245334A JP 2003052806 A JP2003052806 A JP 2003052806A
- Authority
- JP
- Japan
- Prior art keywords
- blood bag
- chlorinated polyethylene
- parts
- weight
- plasticizer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 33
- 239000008280 blood Substances 0.000 title claims abstract description 33
- 239000004709 Chlorinated polyethylene Substances 0.000 claims abstract description 24
- 239000004014 plasticizer Substances 0.000 claims abstract description 18
- 229920005989 resin Polymers 0.000 claims abstract description 12
- 239000011347 resin Substances 0.000 claims abstract description 12
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004800 polyvinyl chloride Substances 0.000 claims description 17
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 17
- -1 phthalate ester Chemical class 0.000 claims description 9
- 239000000460 chlorine Substances 0.000 claims description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 239000004593 Epoxy Substances 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 238000003860 storage Methods 0.000 abstract description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N Diethylhexyl phthalate Natural products CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- DJDSLBVSSOQSLW-UHFFFAOYSA-N mono(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(O)=O DJDSLBVSSOQSLW-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N o-dicarboxybenzene Natural products OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- JJGBFZZXKPWGCW-UHFFFAOYSA-N 2,3-bis[8-[3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoyloxy]propyl 8-[3-[(3-pentyloxiran-2-yl)methyl]oxiran-2-yl]octanoate Chemical compound CCCCCC1OC1CC1C(CCCCCCCC(=O)OCC(COC(=O)CCCCCCCC2C(O2)CC2C(O2)CCCCC)OC(=O)CCCCCCCC2C(O2)CC2C(O2)CCCCC)O1 JJGBFZZXKPWGCW-UHFFFAOYSA-N 0.000 description 1
- 102100028175 Abasic site processing protein HMCES Human genes 0.000 description 1
- 101001006387 Homo sapiens Abasic site processing protein HMCES Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940067597 azelate Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は血液成分特に赤血球
含有液を貯蔵・保存するのに適した、低温時での破損を
低減できる血液バッグに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a blood bag suitable for storing and preserving blood components, especially a liquid containing red blood cells, and capable of reducing damage at low temperatures.
【0002】[0002]
【従来技術及び発明が解決しようとする課題】血液バッ
グに要求される性質としては、採血・輸血・血液成分分
離などの操作を容易にする柔軟性、これらの操作に耐え
得る強度、衛生性、安全性などが挙げられる。可塑剤を
含有した軟質ポリ塩化ビニル(以下軟質PVCともい
う)は上記要求性能をほぼ満たすことから、現在血液バ
ッグ用材料として主流を占めている。2. Description of the Related Art Properties required for a blood bag include flexibility for facilitating operations such as blood collection, blood transfusion, and blood component separation, strength capable of withstanding these operations, and hygiene. Safety etc. are mentioned. Since soft polyvinyl chloride containing a plasticizer (hereinafter also referred to as soft PVC) substantially satisfies the above-mentioned required performance, it is currently the mainstream material for blood bags.
【0003】しかし軟質PVCでは低温時(5℃から−
40℃)での耐久性が低く、使用中における破損も少な
くないため、低温での強度の高い血液バッグへのニーズ
は大きい。そこで本発明は上記状況に鑑み、低温時での
耐久性・強度に優れた血液バッグを提供することを課題
としてなされたものである。However, in flexible PVC, at low temperatures (from 5 ° C-
Since the durability at 40 ° C) is low and the damage during use is not small, there is a great need for a blood bag having high strength at low temperature. Therefore, in view of the above situation, the present invention has been made to provide a blood bag having excellent durability and strength at low temperatures.
【0004】[0004]
【課題を解決するための手段】本発明者らは上記課題を
解決するために鋭意検討を重ねた結果、最初に軟質PV
Cに他のポリマーを添加することを着想し、更に最も好
適なポリマーとして塩素化ポリエチレン(以下C−PE
ともいう)を軟質PVCに添加したシートにより血液バ
ッグを製袋することにより、低温時での耐久性・強度に
優れた血液バッグの発明をなすに至った。Means for Solving the Problems As a result of intensive studies to solve the above-mentioned problems, the present inventors first found that soft PV was used.
Inspired by adding other polymers to C, chlorinated polyethylene (hereinafter C-PE) is the most suitable polymer.
(Also referred to as ()) was made into a sheet by adding a soft PVC to a blood bag, and a blood bag excellent in durability and strength at low temperature was invented.
【0005】[1]本発明は、塩化ビニル樹脂100重
量部に対し、可塑剤30から70重量部及び塩素化ポリ
エチレン5から40重量部を添加して成形したシートよ
り、製袋した血液バッグを提供する。
[2]本発明は、前記塩素化ポリエチレンは非晶性塩素
化ポリエチレンである、[1]に記載の血液バッグを提
供する。
[3]本発明は、前記ポリ塩化ビニル樹脂は重合度が1
000から2500、前記塩素化ポリエチレンは塩素含
有量が25から40質量%である、[1]ないし[2]
に記載の血液バッグを提供する。
[4]前記可塑剤がフタル酸エステル、リン酸エステ
ル、クエン酸エステル、エポキシ系の可塑剤である、
[1]ないし[3]に記載の血液バッグを提供する。[1] The present invention provides a blood bag made from a sheet formed by adding 30 to 70 parts by weight of a plasticizer and 5 to 40 parts by weight of chlorinated polyethylene to 100 parts by weight of vinyl chloride resin. provide. [2] The present invention provides the blood bag according to [1], wherein the chlorinated polyethylene is amorphous chlorinated polyethylene. [3] In the present invention, the polyvinyl chloride resin has a degree of polymerization of 1
000 to 2500, the chlorinated polyethylene has a chlorine content of 25 to 40% by mass, [1] to [2]
The blood bag described in 1. is provided. [4] The plasticizer is a phthalic acid ester, a phosphoric acid ester, a citric acid ester, or an epoxy-based plasticizer,
A blood bag according to any one of [1] to [3] is provided.
【0006】[0006]
【発明の実施の形態】本発明においてはいかなる理論に
拘泥される訳ではないが、ポリ塩化ビニルと塩素化ポリ
エチレン、好ましくは非晶性塩素化ポリエチレンとの適
度な親和性が低温時の耐久性をコントロールしているも
のと考えている。これはポリ塩化ビニルが結晶性ではな
いため、非晶性の塩素化ポリエチレンとの相溶性が高い
からである。BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, although not limited to any theory, a moderate affinity between polyvinyl chloride and chlorinated polyethylene, preferably amorphous chlorinated polyethylene, is durability at low temperature. I think that it controls. This is because polyvinyl chloride is not crystalline and has high compatibility with amorphous chlorinated polyethylene.
【0007】本発明の前記ポリ塩化ビニルは重合度が1
000から2500のものが使用される。重合度が10
00未満では衝撃強度が低く、重合度が2500を超え
ると成形性が悪いため好ましくない。本発明の前記塩素
化ポリエチレン(好ましくは塩素化ポリエチレン)とは、
熱可塑性ポリエチレンの通常公知の方法により塩素化す
ることによって得られる。また塩素の含有量が25から
40質量%のものが使用される。塩素の含有量が25質
量%未満ではポリ塩化ビニル樹脂との親和性が低く、ま
た40質量%を超えると耐寒性が低下するため好ましく
ない。The polyvinyl chloride of the present invention has a degree of polymerization of 1
000 to 2500 are used. Degree of polymerization is 10
When it is less than 00, the impact strength is low, and when the degree of polymerization exceeds 2500, the moldability is poor, which is not preferable. The chlorinated polyethylene of the present invention (preferably chlorinated polyethylene),
It is obtained by chlorinating a thermoplastic polyethylene by a generally known method. A chlorine content of 25 to 40% by mass is used. If the chlorine content is less than 25% by mass, the affinity with the polyvinyl chloride resin is low, and if it exceeds 40% by mass, the cold resistance is deteriorated, which is not preferable.
【0008】ポリ塩化ビニルに添加される塩素化ポリエ
チレンは、PVC樹脂100重量部に対し5から40重
量部、好ましくは8から25重量部が良い。5重量部未
満では期待する4℃から−40℃の取扱い上の耐破損効
果が低下するので好ましくない。また40重量部を超え
るとポリ塩化ビニルと塩素化ポリエチレンの相溶性が低
下し、血液バッグシートとしての透明性、耐衝撃性が十
分に得られないからである。The amount of chlorinated polyethylene added to polyvinyl chloride is 5 to 40 parts by weight, preferably 8 to 25 parts by weight, based on 100 parts by weight of PVC resin. If it is less than 5 parts by weight, the expected damage resistance at 4 ° C. to −40 ° C. in handling deteriorates, which is not preferable. On the other hand, if it exceeds 40 parts by weight, the compatibility between polyvinyl chloride and chlorinated polyethylene decreases, and transparency and impact resistance as a blood bag sheet cannot be sufficiently obtained.
【0009】前記PVC樹脂に添加される可塑剤とし
て、フタル酸エステル、リン酸エステル、クエン酸エス
テル、エポキシ系等の安価な非耐寒性可塑剤のものが使
用される。特にセバシン酸ジオクチルやアゼライン酸ジ
オクチル等の高価な耐寒性可塑剤ではなく、安価な非耐
寒性のフタル酸−2−エチルヘキシル(以下DOPとも
いう)等を添加するのが本発明の耐低温性血液バッグの
製造コスト上有効である。可塑剤はPVC樹脂:100
重量部に対して30から70重量部、好ましくは35か
ら60重量部添加するのが良い。30重量部未満では血
液バッグシートとしての柔軟性に欠ける為好ましくな
い。また70重量部を超えると血液バッグに要求される
強度が得られず、血液バッグシートとしての実用性がな
くなるためである。またその他の添加剤として、エポキ
シ化大豆油(以下ESBOともいう)、ステアリン酸カ
ルシウム、ステアリン酸亜鉛等の安定剤が使用される。As the plasticizer added to the PVC resin, an inexpensive non-cold-resistant plasticizer such as phthalic acid ester, phosphoric acid ester, citric acid ester, and epoxy resin is used. In particular, it is not the expensive cold-resistant plasticizers such as dioctyl sebacate and diazetyl azelate, but the inexpensive non-cold-resistant 2-ethylhexyl phthalate (hereinafter also referred to as DOP), etc., added to the cold-resistant blood of the present invention. It is effective in bag manufacturing cost. Plasticizer is PVC resin: 100
It is advisable to add 30 to 70 parts by weight, preferably 35 to 60 parts by weight, relative to parts by weight. If the amount is less than 30 parts by weight, the flexibility of the blood bag sheet is insufficient, which is not preferable. On the other hand, if it exceeds 70 parts by weight, the strength required for the blood bag cannot be obtained, and the blood bag sheet becomes impractical. As other additives, stabilizers such as epoxidized soybean oil (hereinafter also referred to as ESBO), calcium stearate and zinc stearate are used.
【0010】以上のポリ塩化ビニル樹脂、可塑剤、塩素
化ポリエチレン等を所定の割合で混合し単層シートとし
て成形し、これらのシートを二枚重ね合わせて製袋する
ことにより血液バッグを作成する。シートの厚さは0.
25mmから0.5mm、好ましくは0.35mmから
0.45mmが良い。0.25mm未満では破損しやす
く、0.5mmを超えると製袋性が悪く実用性が低いた
め好ましくない。The above-mentioned polyvinyl chloride resin, plasticizer, chlorinated polyethylene and the like are mixed at a predetermined ratio to form a single layer sheet, and two sheets of these sheets are laminated to form a blood bag. The thickness of the sheet is 0.
The thickness is 25 mm to 0.5 mm, preferably 0.35 mm to 0.45 mm. If it is less than 0.25 mm, it tends to be broken, and if it exceeds 0.5 mm, it is not preferable because it is poor in bag-making property and is not practical.
【0011】[0011]
【実施例】以下本発明を実施例に基づいて具体的に説明
する。本実施例1から実施例3と比較例1では、塩化ビ
ニル樹脂として鐘ヶ淵化学社製S−1003(平均重合
度1300)、塩素化ポリエチレンとして昭和電工社製
302NA(塩素含有率30質量%)、可塑剤としてフ
タル酸−2−エチルヘキシル(DOP)を使用した。
(血液バッグの作製)本実施例1から実施例3では表1
に記載のように塩化ビニル樹脂100重量部に対し、塩
素化ポリエチレン9から21重量部、可塑剤35から4
5重量部、安定剤等を所定の割合で混合し、厚さ0.4
0mmのシート状に成形し、このシートを2枚重ね合わ
せて製袋し、血液バッグを作製した。また比較例1では
表1に記載のように、塩素化ポリエチレンを添加しない
で、可塑剤を実施例1から3より多く(50重量部)添
加し、実施例1から実施例3と同様に血液バッグを作製
した。
(凍結させた血液バッグの破損試験)前記により作製し
た各血液バッグ(300ml容量)を高圧蒸気滅菌した
後、水160ml充填し、そのバッグを−30℃にて24
時間保管した後、高さ1mの所から平らなコンクリート
に、バッグの腹部より落下させ、容器の破損を調べた。
(結果)表1の結果より、本発明の実施例1から3は破
損率が15〜35%で比較例1(75%)よりかなり低
く抑えることができた。EXAMPLES The present invention will be specifically described below based on examples. In Examples 1 to 3 and Comparative Example 1, S-1003 (average degree of polymerization 1300) manufactured by Kanega Fuchi Chemical Co., Ltd. as a vinyl chloride resin, 302NA manufactured by Showa Denko KK as a chlorinated polyethylene (chlorine content 30% by mass) ), And 2-ethylhexyl phthalate (DOP) was used as a plasticizer. (Preparation of blood bag) Table 1 in Examples 1 to 3
As described in the above, with respect to 100 parts by weight of vinyl chloride resin, 9 to 21 parts by weight of chlorinated polyethylene and 35 to 4 parts of plasticizer are used.
5 parts by weight, a stabilizer and the like are mixed at a predetermined ratio to give a thickness of 0.4.
A 0 mm sheet was formed, and two sheets were superposed to form a bag, to prepare a blood bag. Further, in Comparative Example 1, as shown in Table 1, chlorinated polyethylene was not added, but a plasticizer was added in a larger amount than in Examples 1 to 3 (50 parts by weight), and blood was added in the same manner as in Examples 1 to 3. A bag was made. (Damage Test of Frozen Blood Bag) Each blood bag (300 ml capacity) produced as described above was sterilized by high pressure steam and then filled with 160 ml of water, and the bag was kept at -30 ° C. for 24 hours.
After storage for a period of time, the bag was dropped from a height of 1 m onto flat concrete from the abdomen of the bag, and damage to the container was examined. (Results) From the results shown in Table 1, the breakage rate of Examples 1 to 3 of the present invention was 15 to 35%, which was significantly lower than that of Comparative Example 1 (75%).
【0012】[0012]
【表1】 [Table 1]
【0013】[0013]
【発明の作用効果】ポリ塩化ビニルに塩素化ポリエチレ
ンを添加することにより、血液バッグを低温で保存す
る際の取り扱い時の破損率を大幅に減少することができ
る。高価な耐寒性可塑剤を使用することなく、安価な
非耐寒性可塑剤を添加することにより前記の効果を得
られるため、低コストで耐低温性血液バッグを得ること
が可能である。By adding chlorinated polyethylene to polyvinyl chloride, it is possible to greatly reduce the damage rate during handling when the blood bag is stored at a low temperature. Since the above effects can be obtained by adding an inexpensive non-cold-resistant plasticizer without using an expensive cold-resistant plasticizer, it is possible to obtain a low-temperature resistant blood bag at low cost.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C08K 5/00 C08L 27/06 C08L 27/06 27:22 //(C08L 27/06 A61J 1/00 331B 27:22) 331A Fターム(参考) 4C081 AC12 BB08 BC01 BC02 CA022 CA041 CE07 CE10 DA02 DC12 4J002 BD031 BD172 EH096 EH146 EW046 FD026 GB01 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) C08K 5/00 C08L 27/06 C08L 27/06 27:22 // (C08L 27/06 A61J 1/00 331B 27:22) 331A F term (reference) 4C081 AC12 BB08 BC01 BC02 CA022 CA041 CE07 CE10 DA02 DC12 4J002 BD031 BD172 EH096 EH146 EW046 FD026 GB01
Claims (4)
剤30から70重量部及び塩素化ポリエチレン5から4
0重量部を添加して成形したシートより、製袋したこと
を特徴とする血液バッグ。1. A plasticizer 30 to 70 parts by weight and a chlorinated polyethylene 5 to 4 per 100 parts by weight of vinyl chloride resin.
A blood bag characterized by being made into a bag from a sheet formed by adding 0 part by weight.
リエチレンである、ことを特徴とする請求項1に記載の
血液バッグ。2. The blood bag according to claim 1, wherein the chlorinated polyethylene is amorphous chlorinated polyethylene.
0から2500、前記塩素化ポリエチレンは塩素含有量
が25から40質量%である、ことを特徴とする請求項
1ないし請求項2に記載の血液バッグ。3. The polyvinyl chloride resin has a degree of polymerization of 100.
The blood bag according to claim 1 or 2, wherein the chlorine content of the chlorinated polyethylene is 0 to 2500, and the chlorine content is 25 to 40% by mass.
ステル、クエン酸エステル、エポキシ系の可塑剤であ
る、ことを特徴とする請求項1ないし請求項3に記載の
血液バッグ。4. The blood bag according to claim 1, wherein the plasticizer is a phthalate ester, a phosphate ester, a citrate ester, or an epoxy plasticizer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001245334A JP2003052806A (en) | 2001-08-13 | 2001-08-13 | Blood bag |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001245334A JP2003052806A (en) | 2001-08-13 | 2001-08-13 | Blood bag |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003052806A true JP2003052806A (en) | 2003-02-25 |
Family
ID=19075107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001245334A Pending JP2003052806A (en) | 2001-08-13 | 2001-08-13 | Blood bag |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003052806A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2005033197A1 (en) * | 2003-09-30 | 2006-12-14 | 株式会社Adeka | Vinyl chloride resin composition for vehicles |
CN100335553C (en) * | 2004-05-12 | 2007-09-05 | 威海威高创新有限公司 | Soft PVC plastic in use for apparatus transfusions |
JP2013534857A (en) * | 2010-05-24 | 2013-09-09 | ザイレコ,インコーポレイテッド | Chemical processing |
JP2016189934A (en) * | 2015-03-31 | 2016-11-10 | 株式会社ジェイ・エム・エス | Liquid storage bag |
WO2019065763A1 (en) * | 2017-09-27 | 2019-04-04 | 株式会社Technology Gateway | Method and device for freezing blood |
-
2001
- 2001-08-13 JP JP2001245334A patent/JP2003052806A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2005033197A1 (en) * | 2003-09-30 | 2006-12-14 | 株式会社Adeka | Vinyl chloride resin composition for vehicles |
JP4679367B2 (en) * | 2003-09-30 | 2011-04-27 | 株式会社Adeka | Vinyl chloride resin composition for vehicles |
CN100335553C (en) * | 2004-05-12 | 2007-09-05 | 威海威高创新有限公司 | Soft PVC plastic in use for apparatus transfusions |
JP2013534857A (en) * | 2010-05-24 | 2013-09-09 | ザイレコ,インコーポレイテッド | Chemical processing |
JP2016189934A (en) * | 2015-03-31 | 2016-11-10 | 株式会社ジェイ・エム・エス | Liquid storage bag |
WO2019065763A1 (en) * | 2017-09-27 | 2019-04-04 | 株式会社Technology Gateway | Method and device for freezing blood |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0216639A2 (en) | A strong steam-sterilizable multiple-layer film, and packages for physiologic solutions, made therefrom | |
EP0396724B1 (en) | Plastic composition with anti-hemolytic effect | |
US5100401A (en) | Plastic composition with anti-hemolytic effect | |
US5167657A (en) | Plastic composition with anti-hemolytic effect | |
EP0230744B1 (en) | Propylene polymer composition | |
US20050238830A1 (en) | Polymer composition including a cyclic olefin copolymer | |
EP0778030A1 (en) | Container for medical use | |
JP2003052806A (en) | Blood bag | |
NO168119B (en) | APPLICATION OF AN OLEPHIN POLYMER MIXTURE FOR THE PREPARATION OF A STERILIZABLE FILM FOR THE PREPARATION OF PARENTERAL SOLUTION BAGS | |
US20130206634A1 (en) | Package comprising a sterilized content | |
JPS63278841A (en) | Multilayer film for packaging article under controlled atmosphere | |
JP4874784B2 (en) | Polyethylene medical container and laminated film used therefor | |
JPH09154919A (en) | Low temperature resisting blood bag | |
JPH08188687A (en) | Elastomer composition and container for medical care | |
AU713648B2 (en) | Blood component preservation container and multi-linkage container system | |
EP2737999B1 (en) | High abuse heat shrinkable film | |
JP2569675B2 (en) | Polyvinyl chloride composition | |
JPH0356739B2 (en) | ||
JPS6330941B2 (en) | ||
JPH10176089A (en) | Medical container | |
JPS59189154A (en) | Resin composition | |
JPH03218770A (en) | Bag for preserving platelet and composite bag formed by using this bag | |
JPH05237165A (en) | Bag for preserving blood component | |
JPS6350019B2 (en) | ||
JPH021279A (en) | Platelet preserving bag and composite bag using the same |